最新ニュース Cemex (NYSE:CX) 株価情報

Cemex

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.

Cemex SAB de CV

C5 ACQUISITION CORP L A

CXApp Inc

CALIBRE MINING CORP ORD by Calibre Mining Corp.

Calibre Mining Corp

CORIX BIOSCIENCE INC by Corix Bioscience, Inc.

Corix Bioscience Inc

Cardxx Inc

CYPHER METAVERSE INC by CYPHER METAVERSE INC.

Cypher Metaverse Inc

Crexendo Inc

MFS High Income Municipal Trust Common Stock

Mfs High Income Municipal Trust

COMPUTER & TECHS HLDGS by Computer & Technologies Holdings Ltd.

Computer And Technologies Holdings Ltd

MFS Investment Grade Municipal Trust Common Stock

Mfs Investment Grade Municipal Trust

COMMODORE APPLIED TECHS by Commodore Applied Technologies, Inc.

CHINA XLX FERTILISER LTD by China XLX Fertiliser Ltd.

Sprinklr Inc

CargoX

Core Lithium Ltd

CHINA RES MIXC LIFESTYLE by CHINA RES MIXC LIFESTYLE SVCS LTD.

Listed Funds Trust Teucrium 2x Daily Corn ETF

WisdomTree China ex-State-Owned Enterprises Fund

Crane NXT Co

Covalent X Token - United States Dollar

CoreCivic Inc

C21 INVESTMENTS INC ORD by C21 Investments Inc.

C21 Investments Inc

CMX GOLD & SILVER CRP ORD by CMX Gold & Silver Corp

CMX Gold & Silver Corp

RBC Capital analyst Anthony Codling downgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Sector Perform to Underperform and lowers the price target from $6 to $5.

News

Downgrades

Price Target

Analyst Ratings

RBC Capital Downgrades Cemex to Underperform, Lowers Price Target to $5

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $8.9 to $8.2.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.2

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $10 to $8.9.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.9

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Perform and lowers the price target from $6.5 to $6.

RBC Capital Maintains Sector Perform on Cemex, Lowers Price Target to $6

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Vertical Research analyst Kevin McCarthy downgraded the rating for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Sell and announced a $130 price target. Celanese shares closed at $129.97 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Simon Leopold downgraded Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) from Strong Buy to Outperform and slashed the price target from $17 to $14. Harmonic shares closed at $14.82 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Adrian Huerta downgraded CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Overweight to Neutral and lowered the price target from $7 to $6. Cemex shares closed at $5.46 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Oliver Chen downgraded the rating for Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) from Buy to Hold and maintained the price target of $52. Tapestry shares closed at $50.47 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities analyst Mike Crawford downgraded Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) from Buy to Neutral and raised the price target from $8 to $9.5. Redwire shares closed at $9.19 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="523" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-1024x523.png" alt="" class="wp-image-619542" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-768x392.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302.png 1312w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:<a href="https://www.benzinga.com/news/24/10/41598310/jim-cramer-avoid-this-consumer-cyclical-stock-buy-lam-research"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41598310/jim-cramer-avoid-this-consumer-cyclical-stock-buy-lam-research">Jim Cramer: &#8216;Avoid&#8217; This Consumer Cyclical Stock, Buy Lam Research</a></li>
</ul>

Markets

Trading Ideas

HLIT

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported worse-than-expected third-quarter <a href="https://www.benzinga.com/quote/CX/earnings">financial results on Monday</a>.
Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.
Cemex shares fell 8.7% to close at $5.46 on Monday.
These analysts made changes to their price targets on Cemex following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e99cf63d89aa400014fa922/adrian-huerta">JP Morgan analyst Adrian Huerta</a> downgraded Cemex from Overweight to Neutral and lowered the price target from $7 to $6.</li>
<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>
</ul>
Considering buying CX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png" alt="" class="wp-image-619379" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41592226/dow-surges-over-250-points-ahead-of-alphabet-pfizer-earnings-investor-sentiment-improves-fear-index">Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Earnings

Cemex Analysts Slash Their Forecasts After Q3 Results

Barclays analyst Benjamin Theurer maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Overweight and lowers the price target from $9 to $8.

Barclays Maintains Overweight on Cemex, Lowers Price Target to $8

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham cut ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) price target from $92 to $87. Needham analyst Quinn Bolton maintained a Buy rating. ON Semiconductor shares closed at $72.24 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. lowered the price target for Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) from $10 to $9. HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintained a Buy rating. Ekso Bionics shares closed at $1.13 on Monday. <a href="https://www.benzinga.com/quote/EKSO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham slashed the price target for TransMedics Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from $208 to $109. Needham analyst Mike Matson maintained a Buy rating. TransMedics shares closed at $126.24 on Monday. <a href="https://www.benzinga.com/quote/TMDX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group raised V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) price target from $19 to $21. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. V.F. Corporation shares settled at $17.03 on Monday. <a href="https://www.benzinga.com/quote/VFC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) price target from $7 to $6. JP Morgan analyst Adrian Huerta downgraded the stock from Overweight to Neutral. CEMEX shares closed at $5.46 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised Summit Materials, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) price target from $45 to $52. Barclays analyst Adam Seiden upgraded the stock from Equal-Weight to Overweight. Summit Materials shares closed at $45.63 on Monday. <a href="https://www.benzinga.com/quote/SUM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley boosted the price target for Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from $84 to $89. Morgan Stanley analyst Megan Alexander maintained an Overweight rating. Planet Fitness shares settled at $81.25 on Monday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG raised Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) price target from $118 to $124. BTIG analyst Matthew Vanvliet maintained a Buy rating. Agilysys shares closed at $111.49 on Monday. <a href="https://www.benzinga.com/quote/AGYS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities increased the price target for KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) from $150 to $155. JMP Securities analyst Devin Ryan maintained a Market Outperform rating. KKR shares closed at $140.75 on Monday. <a href="https://www.benzinga.com/quote/KKR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG boosted Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) price target from $165 to $185. BTIG analyst Janine Stichter maintained a Buy rating. Boot Barn shares closed at $161.22 on Monday. <a href="https://www.benzinga.com/quote/BOOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying BOOT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="551" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-1024x551.png" alt="" class="wp-image-619173" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294.png 1221w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41592226/dow-surges-over-250-points-ahead-of-alphabet-pfizer-earnings-investor-sentiment-improves-fear-index">Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

AGYS

BOOT

EKSO

PLNT

TMDX

Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

JP Morgan analyst Adrian Huerta downgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Overweight to Neutral and lowers the price target from $7 to $6.

JP Morgan Downgrades Cemex to Neutral, Lowers Price Target to $6

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.77% to 42,440.12 while the NASDAQ rose 0.46% to 18,603.67. The S&amp;P 500 also rose, gaining, 0.43% to 5,832.99.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares rose by 1.2% on Monday.
In trading on Monday, energy shares fell by 0.7%.
Top Headline
Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 106% to $1.19 &nbsp;after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 70% to $13.08 &nbsp;after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 52% to $7.78 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 16% to $26.52 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 7% to $4.38. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 9% to $5.46 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 6% to $67.49 while gold traded down 0.1% at $2,754.40.
Silver traded up 0.2% to $33.850 on Monday, while copper fell 0.1% to $4.3655.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 0.41%, Germany's DAX rose 0.35% and France's CAC 40 rose 0.79%. Spain's IBEX 35 Index rose 0.77%, while London's FTSE 100 rose 0.45%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Equities

Eurozone

Commodities

AMIX

BORR

EVOK

HCTI

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday.
The Dow traded up 0.52% to 42,333.84 while the NASDAQ rose 0.43% to 18,598.02. The S&amp;P 500 also rose, gaining, 0.31% to 5,826.12.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Utilities shares rose by 1.1% on Monday.
In trading on Monday, energy shares fell by 1%.
Top Headline
ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) posted better-than-expected earnings for the third quarter on Monday.
The company posted a revenue decline of 19.2% year-on-year to $1.76 billion, beating the analyst consensus estimate of $1.75 billion. The adjusted EPS of 99 cents beat the analyst consensus estimate of 97 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 159% to $1.50 after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 78% to $13.73 after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 82% to $9.34 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 17% to $26.16 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 11% to $4.1987. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 10% to $5.36 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 5.4% to $67.88 while gold traded up 0.1% at $2,755.50.
Silver traded up 0.3% to $33.890 on Monday, while copper fell 0.1% to $4.3660.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.10%, Germany's DAX fell 0.02% and France's CAC 40 rose 0.39%. Spain's IBEX 35 Index rose 0.37%, while London's FTSE 100 rose 0.16%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Intraday Update

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Guidance

Dividends

Buybacks

Cemex CEO Sees Building On Dividend, Share Buyback Program

WIIM

Cemex shares are trading lower after the company reported worse-than-expected Q3 financial results.

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.19 by 26.32 percent. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion by 4.99 percent. This is a 8.77 percent decrease over sales of $4.483 billion the same period last year.

Earnings Misses

Cemex Q3 2024 GAAP EPS $0.14 Misses $0.19 Estimate, Sales $4.090B Miss $4.305B Estimate

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) is preparing to release its quarterly earnings on Monday, 2024-10-28. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Cemex to report an earnings per share (EPS) of $0.29.
Cemex bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS missed by $0.05, leading to a 0.78% increase in the share price on the subsequent day.
Here's a look at Cemex's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.22</td>
<td>0.12</td>
<td>0.02</td>
<td>0.23</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.17</td>
<td>0.17</td>
<td>-0.30</td>
<td>0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
<td>-4.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729868542_0.png" alt="eps graph" />
<a href="https://www.benzinga.com/quote/CX/earnings">To track all earnings releases for Cemex visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Cemex's Upcoming Earnings

JP Morgan analyst Adrian Huerta maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Overweight and lowers the price target from $8 to $7.

JP Morgan Maintains Overweight on Cemex, Lowers Price Target to $7

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66433a0c6d48530001dc96e5/anthony-codling">RBC Capital analyst Anthony Codling</a> upgraded the rating for CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Underperform to Sector Perform but lowered the price target from $9 to $6.5. Cemex shares fell 0.7% to close at $5.88 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Steven Chubak upgraded Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) from Peer Perform to Outperform and announced a $65 price target. Wells Fargo shares gained 0.4% to close at $57.16 on Monday. <a href="https://www.benzinga.com/quote/WFC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59d7dc9c6ab1240001d3a462/vernon-bernardino">HC Wainwright &amp; Co. analyst Vernon Bernardino</a> upgraded the rating for Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) from Neutral to Buy and announced a price target of $116. Cassava Sciences shares fell 6.2% to close at $25.41 on Monday. <a href="https://www.benzinga.com/quote/SAVA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG analyst Vincent Caintic upgraded Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Neutral to Buy and announced a $68 price target. Affirm shares closed at $38.60 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush analyst Jay McCanless upgraded the rating for UFP Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) from Neutral to Outperform and raised the price target from $120 to $155. UFP Industries shares closed at $129.58 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying WFC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="519" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-1024x519.png" alt="" class="wp-image-585560" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-1024x519.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08090857/image-52.png 1342w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41221716/dow-dips-around-400-points-as-treasury-yields-top-4-investor-optimism-declines-but-fear-index-remai">Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Upgrades

AFRM

BCAX

FXNC

SAVA

UFPI

This Wells Fargo Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler raised Nasdaq, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) price target from $73 to $80. Piper Sandler analyst Richard Repetto maintained an Overweight rating. Nasdaq shares fell 1.7% to close at $70.87 on Monday. <a href="https://www.benzinga.com/quote/NDAQ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HC Wainwright &amp; Co raised the price target for Scholar Rock Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRRK#NASDAQ">SRRK</a>) from $30 to $35. HC Wainwright &amp; Co. analyst Andres Maldonado maintained a Buy rating. Scholar Rock shares jumped 362% to close at $34.28 on Monday. <a href="https://www.benzinga.com/quote/SRRK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen cut the price target for Frontier Communications Parent, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FYBR#NASDAQ">FYBR</a>) from $39 to $38.5. TD Cowen analyst Gregory Williams downgraded the stock from Buy to Hold. Frontier Communications Parent shares fell 0.1% to close at $35.32 on Monday. <a href="https://www.benzinga.com/quote/FYBR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital cut CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) price target from $9 to $6.5. RBC Capital analyst Anthony Codling upgraded the stock from Underperform to Sector Perform. CEMEX shares fell 0.7% to close at $5.88 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird boosted Guidewire Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) price target from $175 to $204. Baird analyst Joe Vruwink maintained an Outperform rating. Guidewire Software shares fell 1.1% to close at $182.17 on Monday. <a href="https://www.benzinga.com/quote/GWRE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities slashed First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) price target from $343 to $321. B of A Securities analyst Julien Dumoulin-Smith maintained a Buy rating. First Solar shares fell 0.7% to close at $229.62 on Monday. <a href="https://www.benzinga.com/quote/FSLR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley cut the price target for SolarEdge Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) from $28 to $23. Morgan Stanley analyst Andrew Percoco maintained an Equal-Weight rating. SolarEdge rose 1.4% to close at $20.42 on Monday. <a href="https://www.benzinga.com/quote/SEDG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc raised Tetra Tech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) price target from $49 to $56. Keybanc analyst Sangita Jain maintained an Overweight rating. Tetra Tech shares fell 0.7% to close at $48.01 on Monday. <a href="https://www.benzinga.com/quote/TTEK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler raised the price target for Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) from $136 to $144. Piper Sandler analyst Ryan Todd maintained an Overweight rating. Phillips 66 shares fell 0.1% to close at $138.50 on Monday. <a href="https://www.benzinga.com/quote/PSX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel boosted HubSpot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) price target from $600 to $625. Stifel analyst Parker Lane maintained a Buy rating. HubSpot shares fell 2.4% to close at $522.09 on Monday. <a href="https://www.benzinga.com/quote/HUBS/analyst-ratings">See how other analysts view this stock</a>. </li>
</ul>
Considering buying NDAQ stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="509" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-1024x509.png" alt="" class="wp-image-585403" style="width:841px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-1024x509.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49-768x381.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/08080221/image-49.png 1373w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41221716/dow-dips-around-400-points-as-treasury-yields-top-4-investor-optimism-declines-but-fear-index-remai">Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

FSLR

FYBR

GWRE

HUBS

NDAQ

SEDG

SRRK

TTEK

Nasdaq To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday

RBC Capital analyst Anthony Codling upgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Underperform to Sector Perform and lowers the price target from $9 to $6.5.

RBC Capital Upgrades Cemex to Sector Perform, Lowers Price Target to $6.5

The Berlin-based company processes mineral construction, demolition, and excavation materials (CDEM).&nbsp;This acquisition will integrate with Regenera, Cemex&#39;s business that provides circularity solutions to extend the life cycle of construction products and materials through reuse in value-added products.
The acquired recycling facility can process up to 400,000 tons of material per year, which Regenera will turn into repurposed aggregates for concrete production, reintroducing them into the construction value chain. In addition to its recycling capabilities, RC-Baustoffe Berlin operates the first plant to permanently store biogenic CO₂ in recycled mineral waste in Germany.

Cemex Acquires Majority Stake In RC-Baustoffe Berlin GmbH & Co. KG; No Terms Disclosed

RBC Capital downgraded Cemex (CX) to Underperform from Sector Perform with a price target of $5, down from $6, following the election of Donald Tru...

Cemex downgraded to Underperform from Sector Perform at RBC Capital

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President-...

Trump Trade: Andrew Ferguson tagged as next chair of FTC

Griffon Corporation (GFF) delivered strong financial results for the fourth quarter and fiscal year of 2024, beating analysts' estimates driven by its strengthening profitability, strategic initiatives, and growing industry demand. So, should you buy or hold this stock? Read more to find out... Griffon Corporation (<a href="https://stocknews.com/stock/GFF/">GFF</a>), a leading provider of consumer and professional, and home and building products, reported solid fourth quarter and fiscal year 2024 results, which ended on September 30, 2024. The company's total revenue of $659.67 million for the fourth quarter surpassed the consensus estimate of $641.24 million. Also, its adjusted EPS was $1.47, compared to analysts' expectations of $1.18.
During the fiscal year, the company was able to expand its operations through strategic initiatives. Also, the consistent performance of its Home and Building Products segment, coupled with improving Consumer and Professional Products segment profitability, benefited its financial performance.
Through its strong performance, Griffon was also able to generate $326 million of free cash flow and return to its shareholders in the form of dividends and share repurchases. Through its subsidiaries, the company is widening its horizons and opening new prospects of growth for the future.
According to a report by Market Research Report, the construction materials market is forecasted to grow to a <a href="https://www.marketresearchfuture.com/reports/construction-materials-market-12121">staggering $1.82 trillion by 2032</a> at a CAGR of 4.2%. Factors like government initiatives promoting smart cities, infrastructural development, and environmentally friendly building techniques are driving and enhancing market growth.
For the fiscal year 2025, GFF expects revenue of $2.6 billion, and its adjusted EBITDA is expected to range from $575 million to $600 million, where its 2025 HBP and CPP segment revenue will both be in line with 2024. The company projects 2025 EBITDA margin at HBP to continue to be in excess of 30% and at CPP to be in excess of 9%.
Shares of GFF have gained 17.5% over the past six months to close its last trading session at $78.49. The stock has also soared 45.1% over the past year.
Let's look at factors that could influence GFF's performance in the upcoming months.
Recent Developments
On July 1, GFF's subsidiary, The AMES Companies, Inc., acquired Pope, a leading Australian provider of residential watering products, from The Toro Company (TTC), marking AMES's seventh acquisition in Australia since 2013. The acquisition expanded the company's product portfolio in the Australian market. Pope is projected to contribute approximately $25 million in annualized revenue.
Solid Financials
For the fourth quarter that ended September 30, 2024, GFF's total revenues increased 2.8% year-over-year to $659.67 million. Its adjusted <a href="https://www.investopedia.com/terms/g/grossprofit.asp">gross profit</a> grew 7.8% from the year-ago value to $271.05 million. The company's income from operations rose 40.6% from the prior year's quarter to $111.67 million.
Furthermore, the company's adjusted net income and adjusted EPS came in at $70.94 million and $1.47, up 12.5% and 23.5% from the prior year's quarter, respectively. The company's adjusted EBITDA of $137.53 million indicates growth of 13.4% year-over-year.
Also, GFF's cash and equivalents stood at $114.44 million as of September 30, 2024, compared to $102.89 million as of September 30, 2023.
Robust Historical Growth
GFF's revenue grew at a CAGR of 4.9% over the past three years, while its EBITDA improved at a CAGR of 26.9%. Its EBIT increased at a CAGR of 31.7% over the same period, while the company's net income and EPS grew at respective CAGRs of 38.4% and 41.7% over the same time frame.
Further, the company's normalized net income increased at a CAGR of 37.5% over the same timeframe.
Favorable Analyst Estimates
Analysts expect GFF's revenue for the third quarter (ending June 2025) to come in at $667.64 million, indicating an increase of 3.1% year-over-year. The consensus EPS estimate of $1.54 for the same period reflects a 24% year-over-year improvement. Moreover, the company has maintained an impressive earning history, having topped the consensus revenue and EPS in three of the trailing four quarters.
For the fiscal year (ending September 2026), the company's revenue and EPS are anticipated to grow 3.1% and 17.8% year-over-year to $2.70 billion and $6.52, respectively.
High Profitability
GFF's trailing-12-month EBIT margin of 16.79% is 60.8% higher than the 10.44% industry average. Its trailing-12-month net income margin of 8% is 22.7% higher than the industry average of 6.52%. Likewise, the stock's trailing-12-month gross profit margin of 40.26% is 27.6% higher than the industry average of 31.55%.
Furthermore, the stock's trailing-12-month ROCE, ROTC, and ROTA of 77.72%, 14.13%, and 8.85% are higher than the 13.48%, 7.15%, and 5.28% industry average, respectively.
Lower Valuation
In terms of forward non-GAAP P/E, GFF is currently trading at 14.18x, 32.4% lower than the industry average of 20.98x. The stock's forward EV/EBITDA and Price/Sales of 10.06x and 1.43x are lower than the industry averages of 12.32x and 1.55x, respectively.
Additionally, the stock's forward EV/EBIT and Price/Cash Flow of 11.52x and 10.29x are 33.5% and 36.5% lower than the industry averages of 17.32x and 16.20x, respectively.
POWR Ratings Reflect Promise
GFF's sound fundamentals are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The stock has an overall rating of A, translating to a Strong Buy in our proprietary system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
Our proprietary rating system also evaluates each stock based on eight distinct categories. GFF has a B grade for Value, which is consistent with its lower valuation. The stock has a B grade for Growth, which is in sync with its solid financial performance and historical growth.
Also, the stock has a B grade for Quality, justified by its higher than industry profitability.
GFF has topped among the 42 stocks in the B-rated <a href="https://stocknews.com/category/industrial-building-materials/">Industrial – Building Materials</a> industry.
Beyond what I have stated above, we have also given GFF grades for Momentum, Sentiment, and Stability. Get access to all the GFF ratings <a href="https://stocknews.com/stock/GFF/">here</a>.
Bottom Line
GFF reported solid financial results in the last reported quarter. Further, the company's long-term prospects appear promising, driven by its capacity expansion, strategic acquisitions, and investments.
Moreover, the board of directors of GFF returned a total of $310 million through a quarterly dividend of $0.18 per share and raised share repurchases. This reflects its sound financial standing in the year.
Given GFF's solid financials, accelerating profitability, and lower valuation, investing in the stock could be suitable.
How Does Griffon Corporation (GFF) Stack Up Against Its Peers?
While GFF has an overall POWR Rating of A, investors could also check out these other stocks within the B-rated <a href="https://stocknews.com/category/industrial-building-materials/">Industrial – Building Materials</a> industry with A (Strong Buy) or B (Buy) ratings: Daikin Industries Ltd. ADR (<a href="https://stocknews.com/stock/DKILY/">DKILY</a>), Apogee Enterprises, Inc. (<a href="https://stocknews.com/stock/APOG/">APOG</a>), and Cemex, S.A.B. de C.V. Sponsored ADR (<a href="https://stocknews.com/stock/CX/">CX</a>).
For exploring more A and B-rated industrial stocks, <a href="https://stocknews.com/category/industrial-building-materials/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
GFF shares were trading at $78.96 per share on Monday afternoon, up $0.47 (+0.60%). Year-to-date, GFF has gained 30.70%, versus a 29.02% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/gff-dkily-apog-cx-is-griffon-corporations-diversified-portfolio-a-reason-to-buy-the/>Is Griffon Corporation's Diversified Portfolio a Reason to Buy the Stock?</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Is Griffon Corporation's Diversified Portfolio a Reason to Buy the Stock?

Cementos Argos: An Appealing Cement Play With A Big Payday Coming

Lazard Emerging Markets Equity Portfolio Q3 2024 Commentary

Lazard Retirement Emerging Markets Equity Portfolio Q3 2024  Commentary

Cemex SAB ( ($CX) ) has provided an update. Cemex announced that it will release its fourth quarter 2024 financial results on February 6, 2025, acc...

Cemex to Announce Q4 2024 Financial Results in February 2025

Cemex SAB ( ($CX) ) has provided an update. Cemex has announced the completion of the sale of its operations in the Dominican Republic and business...

Cemex Completes $950M Sale of Caribbean Operations

APOG

BABA

BABAF

BZZUF

BZZUY

CMTOY

CMTSY

CPAC

CXMSF

DKILY

GBOOF

GBOOY

HXSCF

ICUI

JDCMF

LOMA

MDTTF

NDBKF

NDBKY

ONON

PIAIF

PNGAY

SHOO

SSNLF

Press Releases

Standard & Poor's Upgrades Cemex to Investment Grade

Fitch Ratings Upgrades Cemex to Investment Grade

Cemex Tops Industry in 2024 Climate and Energy Benchmark

Cemex and MPP collaborate to accelerate decarbonization projects

Cemex Partners With the Ellen MacArthur Foundation to Accelerate Circular Economy Efforts in the Built Environment

Cemex expands Regenera circularity business with acquisition in Berlin

Fortune Recognizes Cemex for the Fourth Time as a Company That Is Changing the World

EU Backs Pioneering CO2 Capture Project at Cemex's Rüdersdorf Cement Plant

Cemex Recognized at COP29 for Solar Clinker Breakthrough

Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares)

Comments

Cemex

ニュース

最新ニュース Cemex (NYSE:CX) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル